These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
375 related articles for article (PubMed ID: 30067923)
1. Sequencing of Circulating Cell-free DNA during Pregnancy. Bianchi DW; Chiu RWK N Engl J Med; 2018 Aug; 379(5):464-473. PubMed ID: 30067923 [TBL] [Abstract][Full Text] [Related]
2. Pregnant women with confirmed neoplasms should not have noninvasive prenatal testing. Lenaerts L; Van Calsteren K; Che H; Vermeesch JR; Amant F Prenat Diagn; 2019 Nov; 39(12):1162-1165. PubMed ID: 31393011 [TBL] [Abstract][Full Text] [Related]
3. Cherchez la femme: maternal incidental findings can explain discordant prenatal cell-free DNA sequencing results. Bianchi DW Genet Med; 2018 Sep; 20(9):910-917. PubMed ID: 29215645 [TBL] [Abstract][Full Text] [Related]
4. Maternal chromosome Xp deletion identified by prenatal cell-free DNA screening. Ilagan BJ; Maxwell MD; Fisher BM; Milanovich J; Owen R; Anderson B; Zhang K; Strom CM Prenat Diagn; 2017 Sep; 37(9):935-937. PubMed ID: 28654736 [No Abstract] [Full Text] [Related]
5. Accuracy and clinical value of maternal incidental findings during noninvasive prenatal testing for fetal aneuploidies. Brison N; Van Den Bogaert K; Dehaspe L; van den Oever JM; Janssens K; Blaumeiser B; Peeters H; Van Esch H; Van Buggenhout G; Vogels A; de Ravel T; Legius E; Devriendt K; Vermeesch JR Genet Med; 2017 Mar; 19(3):306-313. PubMed ID: 27584908 [TBL] [Abstract][Full Text] [Related]
6. Non-invasive prenatal testing for fetal inheritance of maternal β-thalassaemia mutations using targeted sequencing and relative mutation dosage: a feasibility study. Xiong L; Barrett AN; Hua R; Ho S; Jun L; Chan K; Mei Z; Choolani M BJOG; 2018 Mar; 125(4):461-468. PubMed ID: 29211324 [TBL] [Abstract][Full Text] [Related]
7. Targeted cell-free DNA analysis with microarray quantitation for assessment of fetal sex and sex chromosome aneuploidy risk. Jones KJ; Wang E; Bogard P; White K; Schmid M; Stokowski R; Nicolaides KH Ultrasound Obstet Gynecol; 2018 Feb; 51(2):275-276. PubMed ID: 29160607 [No Abstract] [Full Text] [Related]
8. Analysis of fetal DNA in maternal plasma with markers designed for forensic DNA mixture resolution. Moriot A; Hall D Genet Med; 2019 Mar; 21(3):613-621. PubMed ID: 30072742 [TBL] [Abstract][Full Text] [Related]
9. Inferring fetal fractions from read heterozygosity empowers the noninvasive prenatal screening. Dang M; Xu H; Zhang J; Wang W; Bai L; Fang N; Liang L; Zhang J; Liu F; Wu Q; Wang S; Guan Y Genet Med; 2020 Feb; 22(2):301-308. PubMed ID: 31467446 [TBL] [Abstract][Full Text] [Related]
10. A rare Down syndrome foetus with de novo 21q;21q rearrangements causing false negative results in non-invasive prenatal testing: a case report. Xu HH; Dai MZ; Wang K; Zhang Y; Pan FY; Shi WW BMC Med Genomics; 2020 Jul; 13(1):96. PubMed ID: 32631433 [TBL] [Abstract][Full Text] [Related]
11. De novo HRAS gene mutation associated with Costello syndrome identified by non-invasive cell-free fetal DNA screening. Nwakalor C; Said-Delgado S; Krinshpun S; Velinov M Prenat Diagn; 2021 Jan; 41(1):11-14. PubMed ID: 32681669 [No Abstract] [Full Text] [Related]
12. Correlation between Z score, fetal fraction, and sequencing reads in non-invasive prenatal testing. Balslev-Harder M; Richter SR; Kjaergaard S; Johansen P Prenat Diagn; 2017 Sep; 37(9):943-945. PubMed ID: 28726258 [No Abstract] [Full Text] [Related]
13. Fetal gender adjustment decreases the expected variance in non-invasive prenatal testing analysis. Johansen P; Duno M; Kjaergaard S Prenat Diagn; 2014 May; 34(5):508-9. PubMed ID: 24752637 [No Abstract] [Full Text] [Related]
14. Separating the signal from the noise in metagenomic cell-free DNA sequencing. Burnham P; Gomez-Lopez N; Heyang M; Cheng AP; Lenz JS; Dadhania DM; Lee JR; Suthanthiran M; Romero R; De Vlaminck I Microbiome; 2020 Feb; 8(1):18. PubMed ID: 32046792 [TBL] [Abstract][Full Text] [Related]
15. Rate of no result in cell-free DNA testing and its influence on test performance metrics. Grati FR; Kagan KO Ultrasound Obstet Gynecol; 2017 Jul; 50(1):134-137. PubMed ID: 27731527 [No Abstract] [Full Text] [Related]
16. Identification of fetal unmodified and 5-hydroxymethylated CG sites in maternal cell-free DNA for non-invasive prenatal testing. Gordevičius J; Narmontė M; Gibas P; Kvederavičiūtė K; Tomkutė V; Paluoja P; Krjutškov K; Salumets A; Kriukienė E Clin Epigenetics; 2020 Oct; 12(1):153. PubMed ID: 33081811 [TBL] [Abstract][Full Text] [Related]
17. Noninvasive prenatal testing: from aneuploidy to single genes. Guseh SH Hum Genet; 2020 Sep; 139(9):1141-1148. PubMed ID: 31555907 [TBL] [Abstract][Full Text] [Related]
18. Uncertainty of fetal fraction determination in Non-Invasive Prenatal Screening by highly polymorphic SNPs. Grendár M; Loderer D; Laučeková Z; Švecová I; Hrtánková M; Hornáková A; Nagy B; Žúbor P; Lasabová Z; Danko J J Biotechnol; 2019 Jun; 299():32-36. PubMed ID: 31034863 [TBL] [Abstract][Full Text] [Related]
19. The Combining Effects of Cell-Free Circulating Tumor DNA of Breast Tumor to the Noninvasive Prenatal Testing Results: A Simulating Investigation. Cai YH; Yao GY; Chen LJ; Gan HY; Ye CS; Yang XX DNA Cell Biol; 2018 Jul; 37(7):626-633. PubMed ID: 29957029 [TBL] [Abstract][Full Text] [Related]
20. Noninvasive detection of fetal subchromosomal abnormalities by semiconductor sequencing of maternal plasma DNA. Yin AH; Peng CF; Zhao X; Caughey BA; Yang JX; Liu J; Huang WW; Liu C; Luo DH; Liu HL; Chen YY; Wu J; Hou R; Zhang M; Ai M; Zheng L; Xue RQ; Mai MQ; Guo FF; Qi YM; Wang DM; Krawczyk M; Zhang D; Wang YN; Huang QF; Karin M; Zhang K Proc Natl Acad Sci U S A; 2015 Nov; 112(47):14670-5. PubMed ID: 26554006 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]